Petro pide revisar tarifas de medicamentos ante la caída del dólar en Colombia: ‘Deben rebajar su precio en pesos’

TL;DR

President Petro wants drug prices reviewed due to the Colombian peso's revaluation.
Most medication components are imported, suggesting prices should decrease as the peso strengthens.
The Colombian Pharmaceutical Industry Association (Ascif) warns of critical challenges to local drug production.
Factors affecting drug costs include labor increases, regulatory demands, credit costs, and payment delays in the health system.
Ascif's director stated that the industry lacks guarantees for investing in high-cost medication production.
The Colombian peso experienced volatility, trading below $3,600 but then rising back towards $3,640.

Continuer la lecture de l'article original